Inhibition of p38 mitogen-activated protein kinase augments progression of remnant kidney model by activating the ERK pathway
about
Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activationProfiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damageEffects of the mTOR inhibitor rapamycin on monocyte-secreted chemokinesInhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.Inhibiting ERK Activation with CI-1040 Leads to Compensatory Upregulation of Alternate MAPKs and Plasminogen Activator Inhibitor-1 following Subtotal Nephrectomy with No Impact on Kidney Fibrosis.Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model.The role of stress-activated protein kinase signaling in renal pathophysiology.Phosphorylation of DGCR8 increases its intracellular stability and induces a progrowth miRNA profile.Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation.Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways.Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease.MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin model.
P2860
Q24294309-E5223C1F-5312-4B73-9D10-901776C1B0BEQ28583646-F6AB8F12-01E3-4692-9E9C-A4887EBF4F46Q35278760-A889EB26-F781-43F7-974B-28FE194C69BFQ35607297-85155E45-6472-4C7F-BB29-1819D8B1504BQ35790612-0A97BF15-8BE0-48E3-A3CB-03EB3400E8DBQ36764263-3502C60A-1B83-4A65-B7D5-F360D136E8D9Q37316623-AC312E78-006D-4071-9E8D-EA7AF4BFBEE7Q37483222-63E0C26C-AA2E-4F1F-9C61-1CC9ACAB157EQ40537092-0D4FDD36-4DD8-4692-A598-5C76B570495CQ42490553-93577DBE-7ADA-40A0-BA59-8C5BAC6A8A16Q43259009-F0219C68-EDC0-47D1-8ACE-772E845D4CD6Q43447839-FEDBB249-AA5D-479F-ABA9-C5595033707FQ46746653-6D68375B-0F68-41F8-B330-1BE181B6B60E
P2860
Inhibition of p38 mitogen-activated protein kinase augments progression of remnant kidney model by activating the ERK pathway
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@ast
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@en
type
label
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@ast
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@en
prefLabel
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@ast
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@en
P2093
P2860
P1476
Inhibition of p38 mitogen-acti ...... by activating the ERK pathway
@en
P2093
George F Schreiner
John Kanellis
Ramona G Almirez
Richard J Johnson
Ryuji Ohashi
Susumu Watanabe
Takahiko Nakagawa
P2860
P304
P356
10.1016/S0002-9440(10)63138-0
P407
P577
2004-02-01T00:00:00Z